Immunotherapy Superior for Front-Line mRCC

Clinical trial findings presented at European Society for Medical Oncology (ESMO) 2017 Congress in Madrid, Spain, could signal a major shift in the front-line treatment of metastatic renal cell carcinoma (mRCC).

Proximal PSA Predicts PCa Metastasis Risk

Proximal PSA levels of 10 ng/mL or higher in men with biochemically recurrent prostate cancer (PCa) after radical prostatectomy and a PSA doubling time (PSADT) less than 12 months independently predicts imminent development of metastasis, according to study findings presented at the European Society for Medical Oncology 2017 Congress in Madrid.

CKD Higher With Intensive BP Control

Intensively reducing systolic blood pressure to less than 120 mm Hg increases the risks for chronic kidney disease (CKD), but concurrently decreases the chances of premature death, according to a secondary analysis of SPRINT.

Prostate Cancer Screening Saves Lives

Screening for prostate cancer (PCa) decreases the risk of dying from the malignancy, researchers concluded based on an analysis of data from 2 randomized trials that came to conflicting conclusions about the survival benefit.

Vitamin D Doesn't Reduce Anemia

Taking a daily vitamin D supplement does not prevent or improve anemia in patients with advanced heart failure, including those with concurrent chronic kidney disease (CKD), according to new study findings.

CKD Raises Tinnitus Risk

Chronic kidney disease (CKD) is associated with an increased risk of tinnitus, researchers reported online in PLoS One.

Balancing Security, Data Access

The challenge with information security is walking the line between tightly securing data and over-relaxing access.

MRI in Prostate Cancer Management

Ashutosh K. Tewari, MBBS, MCh, Chair of Urology at the Icahn School of Medicine at Mount Sinai Hospital in New York, is scheduled speak about the emergence of magnetic resonance imaging (MRI) screening for prostate cancer at the 2nd International Prostate Cancer Symposium and Inaugural World Congress of Urologic Oncology. The conference is being held at the Icahn School of Medicine from September 6-9.

Liraglutide Linked With Lower Diabetic Kidney ...

Diabetic kidney disease is less likely to develop or progress in patients with type 2 diabetes treated with liraglutide, a glucagon-like peptide 1 (GLP-1) agonist.

Evaluating Practice Options

Partnering with another organization may provide multiple benefits, including support for participating in new value-based agreements, infrastructure to comply with regulations and access to the capital needed to fund technological investments and growth.

Looking for a Job?

Access our job board to view over 1,000 job openings throughout the US.

RUN Social Media Survey

Tell us about your social media habits for a chance to win a free gift card.


Sign Up for Free e-newsletters